StockSelector.com
  Research, Select, & Monitor Friday, February 12, 2016 11:00:27 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
   Diversify with StockSelector.com
- the tools for short-term traders and long-term investors to find successful ideas to fit their strategies and to keep informed of the stocks you follow or hold. Take a macro look at the market and by industry, narrow down to specific stocks and the right time, then use our portfolio to monitor the stocks and be alerted of changes.


 Sector ETF's Price Change  
Consumer Discret Select Sector SPDR 69.11 0.85%
Consumer Staples Select Sector SPDR 49.79 0.85%
Energy Select Sector SPDR 54.69 1.54%
Financial Select Sector SPDR 20.17 2.59%
Healthcare Select Sector SPDR 63.50 (0.03%)
Industrial Select Sector SPDR 49.26 1.17%
Materials Select Sector SPDR 39.41 1.60%
Technology Select Sector SPDR 38.93 0.52%
Utilities Select Sector SPDR 45.67 (0.07%)

 Most Oversold Industry
 Auto Manufacturers - Major
These firms are some of the largest vehicle manufacturers in the world. They produce the obvious cars, trucks, buses, vans, and motorcycles. Recreational vehicles, mini-vans, luxury cars, components, and construction equipment are some of their other related items on the production lines. Many firms also offer financing of their goods and in a field tied to vehicle financing, one firm here offers mortgages and even auto and homeowner's insurance. They typically sell their product to the consumer through auto dealerships located domestically and abroad.


Michael Kors Beats
2/2/2016 6:55:00 AM


0.85%
Michael Kors Holdings Limited (KORS) reported third quarter earnings of $1.59 per share on revenue of $1.40 billion. The consensus earnings estimate was $1.46 per share on revenue of $1.36 billion for the quarter ending December 31, ... more

Seagate Beats
1/29/2016 8:00:04 AM



0.17%
Seagate Technology plc (STX) reported second quarter earnings of $0.82 per share on revenue of $2.99 billion. The consensus earnings estimate was $0.71 per share on revenue of $2.94 billion for the quarter ending December 31, 2015. ... more

Caterpillar Reports In-line
1/28/2016 7:30:00 AM



1.66%
Caterpillar, Inc. (CAT) reported fourth quarter earnings of $0.74 per share on revenue of $11.03 billion. The consensus earnings estimate was $0.69 per share on revenue of $11.4 billion for the quarter ending December 31, 2015. The ... more

QUALCOMM Beats by a Penny
1/27/2016 4:05:00 PM



1.58%
QUALCOMM Incorporated (QCOM) reported first quarter earnings of $0.97 per share on revenue of $5.78 billion. The consensus earnings estimate was $0.90 per share on revenue of $5.69 billion for the quarter ending December 31, 2015. ... more

Boeing Beats
1/27/2016 7:30:00 AM



0.11%
Boeing Co. (BA) reported fourth quarter earnings of $1.60 per share on revenue of $23.57 billion. The consensus earnings estimate was $1.35 per share on revenue of $23.55 billion for the quarter ending December 31, 2015. The Earnings ... more

Coach Reports In-line
1/26/2016 6:45:00 AM



0.21%
Coach Inc. (COH) reported second quarter earnings of $0.68 per share on revenue of $1.27 billion. The consensus earnings estimate was $0.65 per share on revenue of $1.28 billion for the quarter ending December 31, 2015. The Earnings ... more

 StockSelector's Top Ranked Stock
 Lannett Company Inc
Positive Points:17
Negative Points:5
Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.

 Potential Breakout Stock
 Oncothyreon Inc
Oncothyreon Inc., formerly Biomira Inc. is a clinical-stage biopharmaceutical company focused primarily on the development and commercialization of therapeutic products for the treatment of cancer. The company is currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. Headquartered in Seattle, Washington, the primary goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. The Company's lead product candidate is Stimuvax, which is a cancer vaccine in Phase III development for non-small cell lung cancer. Oncothyreon has an exclusive, worldwide collaboration agreement with Merck KGaA of Darmstadt, Germany, for the development and commercialization of Stimuvax. Its pipeline of clinical and preclinical-stage small molecule product candidates includes PX-12, PX-478 and PX-866, from ProlX Pharmaceuticals Corporation.











Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Quotes are delayed by 15-20 minutes. Quotes provided by QuoteMedia

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2016 StockSelector.com. All rights reserved.